Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Urologic Oncology|June 18, 2017
Commentary on "Biallelic inactivation of BRCA2 in platinum-sensitive metastatic castration-resistant prostate cancer". Cheng HH, Pritchard CC, Boyd T, Nelson PS, Montgomery B. Eur Urol. Jun 2016;69(6):992-5Stephen Freedland, William AronsonBMC Medicine|January 10, 2015
Nutrition, dietary interventions and prostate cancer: the latest evidencePao-Hwa Lin, William Aronson, Stephen J FreedlandUrologic Oncology|November 7, 2017
An update of research evidence on nutrition and prostate cancerPao-Hwa Lin, William Aronson, Stephen J FreedlandUrology|August 25, 2018
A Case of an Invisible Ureteral StentRajiv Jayadevan, Stephanie Pannell, Ryan Chuang, et al.European Urology|November 29, 2011
The correlation between metabolic syndrome and prostatic diseasesCosimo De Nunzio, William Aronson, Stephen J Freedland, et al.Prostate Cancer and Prostatic Diseases|September 7, 2023
Relative search popularity of five advanced prostate cancer medications using Google TrendsSanjay Das, Nadine A Friedrich, James Daniels, et al.Urology|October 10, 2013
Building a medical neighborhood in the safety net: an innovative technology improves hematuria workupsJonathan Bergman, Katherine Neuhausen, Karim Chamie, et al.Clinical Genitourinary Cancer|April 24, 2020
Phase 2 Trial of GTx-758, an Estrogen Receptor Alpha Agonist, in Men With Castration-Resistant Prostate CancerEvan Y Yu, Michael L Hancock, William Aronson, et al.Clinical Genitourinary Cancer|May 17, 2023
The Impact of Blue Light Cystoscopy Use Among Nonmuscle Invasive Bladder Cancer Patients in an Equal Access Setting: Implications on Recurrence and Time to RecurrenceSanjay Das, Lin Gu, Claire Trustram Eve, et al.JAMA Network Open|June 3, 2021
Time Trends in Use of Radical Prostatectomy by Tumor Risk and Life Expectancy in a National Veterans Affairs CohortKristina Vaculik, Michael Luu, Lauren E Howard, et al.Pageof 3